Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DMAC/Net margin

DiaMedica Therapeutics Inc. (DMAC) Net margin

DiaMedica Therapeutics Inc. (DMAC) net profit margin by fiscal year — reported net income divided by reported revenue.

-2129.8%FY2019
19
Fiscal yearValueYoY
FY2019-2129.8%—

Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.

Source: SEC XBRL filings · For reference only · Not investment advice

More DMAC financial trends

DMAC RevenueDMAC Net incomeDMAC Gross profitDMAC Gross marginDMAC Operating incomeDMAC Operating marginDMAC Operating cash flowDMAC Free cash flowDMAC Capital expendituresDMAC Return on equityDMAC Stock buybacksDMAC Dividends paidDMAC Total assetsDMAC Total liabilitiesDMAC Shareholders’ equityDMAC overview →